Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Ginkgolide B protects EPCs from H2O2-induced cell death
intraperitoneal injections) lowers brain Aβ 40 by 37% in guinea pigs
Smiles: C1CN(CCCCC2=NNN=N2)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21
4]triazin-6-yl]carbamate
Shweta Joshi
Avatrombopag Catalog No.:M11396-10 Ginkgolide B protects EPCs fromAvatrombopag, also known as AKR 501, YM477, AS 1670542 or E5501, is a novel orally active thrombopoietin (TPO) receptor agonist. AKR 501 specifically targeted the TPO receptor and stimulated megakaryocytopoiesis throughout the development and maturation of megakaryocytes just as rhTPO did. AKR 501 may be useful in the treatment of patients with thrombocytopenia. Avatrombopag was first approved in 2018. Product information CAS Number: 570406 98 3
US$ 8477.96
US$ 3879.34
US$ 776.55
US$ 765.27
US$ 970.42
US$ 55.93